Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if the Government will publish information on the effectiveness of each type of covid-19 vaccine on (a) immuno-suppressed and (b) other clinically vulnerable people to encourage people in those groups to take up those vaccines.

Public Health England is monitoring the effectiveness and impact of COVID-19 vaccines on a broad range of outcomes including symptomatic disease, infection and hospitalisations as set out in the COVID-19 vaccine surveillance strategy which is available at the following link:

https://www.gov.uk/government/publications/covid-19-vaccine-surveillance-strategy

Vaccine effectiveness assessments are reported regularly to the Joint Committee on Vaccination and Immunisation (JCVI) to inform vaccine policy recommendations. This will include assessment of vaccine effectiveness in immunocompromised individuals and the clinically vulnerable using general practice electronic health record data. Vaccine effectiveness data will be published in due course.

Once sufficient evidence becomes available, the JCVI will consider options for a protection strategy for immunosuppressed individuals, including whether any specific vaccine is preferred in this population.